There are 61 (9%) feminine urologist enrolled at Sociedad Colombiana de Urología. 41 (40%) of urology residentes in Colombia are ladies. The purpose of this examine is to exhibit the work tendencies of feminine urologist, feminine residents and affected person’s preferences relating to the gender of their urologist. MATERIALS AND METHODS: Descriptive observational sectional examine with nameless surveys carried out to working towards feminine urologists, feminine residents, and sufferers.
The questions evaluated the demographic traits of the surveyed people; the questions for feminine urologists evaluated their work tendencies; for the residents we evaluated their plans as urologists; and the sufferers have been requested about their preferences to be evaluated in medical session and to have a surgical procedure carried out by both a male or feminine urologist. RESULTS: The survey was answered by 53 feminine urologists.
The common age was 37 years, the bulk (54%) labored in Bogotá. 34% have subspecialized, the bulk in andrology (16%) endourology (16%) and pediatric urology (16%). Most of them (73.6%) carry out surgical procedure between 5-20 hours weekly, and essentially the most carried out surgical procedure was varicocelectomy. 34% referred to have been harassed of their work surroundings based mostly on their gender.Thirty-six feminine residents answered the survey. Th eaverage age was 28 years.
The common variety of tutorial publications was 3. 80% want to obtain a sub-specialization, of which 24% would do it in endourology. 41% referred to have been harassed. 188 sufferers answered the survey, 96 males and 87 ladies; 44.1% most well-liked to be attended in medical session by a feminine urologist, and 49.2% most well-liked to be operated by a male urologist. CONCLUSIONS: The variety of feminine urologists has exponentially elevated, simply as the share of feminine residents. Feminine residents want to subspecialize in various areas. Sufferers desire to be attended by a feminine urologist in medical session however desire to have surgical procedure carried out by a male urologist.
Microbiome research in urology– the place will we stand and the place can we attain?
The position of microbiome milieu within the urinary tract, their interaction in various urological circumstances and their therapeutic implications should not utterly understood. The microbiome has contributed in the direction of urinary tract infections, urolithiasis and urological cancers. The potential of manipulating microbiome for prognosis and remedy is evolving. Probiotics would possibly assist in overcoming the issues of recurrent an infection and antibiotic resistance.
Novel purposes like stents and catheters coated with non-pathogenic organisms are being developed. Analysis within the urinary microbiome has progressed from utilizing mouse fashions to the presently out there three- dimensional cultured organoids, thus making it extra possible. As our information relating to the urinary microbiome will increase, justice might be carried out to many sufferers in whom the developments can be utilized for prophylaxis, prognosis, remedy and even in enhancing their high quality of life.
The rising quantity of antibiotic resistance can be a matter of concern and probiotics is perhaps the reply to this upcoming calamity. On this assessment, we’ve mentioned the position of the urinary microbiome in pathogenesis, prognosis and remedy of urological circumstances and contemplated upon its future prospects.
Way of life in urology: Benign illnesses
Modifiable lifestyle-related threat elements are the thing of accelerating consideration, with a view to main and tertiary prevention, to restrict the onset and improvement of illnesses.Additionally within the urological area there may be accumulating proof of the connection between urological illnesses and lifestyle-related threat elements that may affect their incidence and prognosis.
Danger elements resembling diet, bodily exercise, sexual habits, tobacco smoking, or alcohol consumption might be modified to restrict morbidity and scale back the social impression and the burdensome prices related to prognosis and remedy.
This assessment synthesizes the present scientific proof out there on this subject, attempting to fulfill the necessity for a abstract on the relationships between crucial way of life elements and the primary benign urological illnesses, specializing in benign prostatic hyperplasia (BPH), infections urinary tract (UTI), urinary incontinence (UI), stones, erectile dysfunction, and male infertility.
COVID-19 in european urology : Which classes have we realized?
The coronavirus has challenged all medical methods worldwide. Herein each waves of COVID-19 (coronavirus illness 2019) in spring and autumn 2020 differ principally. Whereas Europe was hit by the primary wave roughly unprepared, which was aggravated by the excessive virulence of COVID-19, the second wave is characterised by a a lot larger contagiosity of the virus with very excessive incidences.
However the virus has attenuated, which is mirrored by the considerably decrease incidence-related mortality fee. Nonetheless, the general rising variety of contaminated sufferers represents once more an important problem for the medical administration of the illness. France and Spain are doing higher compared to Germany and Italy this time.
Absolutely the variety of deaths per week is larger than throughout the peak of the primary wave. Nonetheless, urologists in these nations have additionally skilled better restrictions of their actions within the second shutdown than in Germany, the place there may be solely a discount of beds to between 75 and 90%.
Largely all ranges are operated. Of significance for Germany, nevertheless, is the plateau on a excessive degree for a number of weeks most likely because of the decreased efficacy of a lightweight lock-down. This lastly resulted in a complete lock-down in mid-December 2020. Subsequently in Germany some hospitals are additionally reaching their limits with related penalties for the departments of urology going through a 50% discount of beds and working solely degree III and IV indications.
Mouse LIF Protein |
E40MOP2026 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2028 |
EnoGene |
20ug |
EUR 495 |
Recombinant Mouse LIF |
Z200195 |
ABM |
10 µg |
EUR 85 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200197 |
ABM |
100 µg |
EUR 385 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200199 |
ABM |
1.0 mg |
EUR 1200 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200485 |
ABM |
100 µg |
EUR 1500 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
anti- LIF antibody |
FNab09804 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against LIF |
Mouse LIF ELISA Kit |
E28L0650 |
EnoGene |
96T |
EUR 666.67 |
Mouse LIF ELISA Kit |
EK5250 |
SAB |
96 tests |
EUR 599 |
|
Mouse LIF ELISA Kit |
EML0014 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse LIF shRNA Plasmid |
20-abx971321 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Mouse LIF Recombinant Protein |
M30-007 |
ReliaTech |
10 µg |
EUR 99.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Mouse LIF Recombinant Protein |
M30-008 |
ReliaTech |
50 µg |
EUR 246.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Recombinant Mouse LIF Protein |
R01400-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
Recombinant Mouse LIF Protein |
PKSM041100-100ug |
Elabscience Biotech |
100ug |
EUR 739 |
|
Description: Mouse |
Recombinant Mouse LIF Protein |
PKSM041100-20ug |
Elabscience Biotech |
20ug |
EUR 249 |
|
Description: Mouse |
Mouse LIF PicoKine ELISA Kit |
EK0580 |
BosterBio |
96 wells |
EUR 510 |
Description: For quantitative detection of mouse LIF in cell culture supernates, serum and plasma (heparin, EDTA). |
Anti-Human LIF Antibody |
101-M553 |
ReliaTech |
100 µg |
EUR 399 |
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Human LIF Antibody |
102-PA05S |
ReliaTech |
100 µg |
EUR 126 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Lif ORF Vector (Mouse) (pORF) |
ORF049145 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Lif ORF Vector (Mouse) (pORF) |
ORF049146 |
ABM |
1.0 ug DNA |
EUR 607.2 |
LIF ELISA Kit (Mouse) (OKBB00760) |
OKBB00760 |
Aviva Systems Biology |
96 Wells |
EUR 606 |
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-001 |
GenDepot |
1ml |
EUR 406.8 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-005 |
GenDepot |
5x1ml |
EUR 1431.6 |
LIF ELISA Kit (Mouse) (OKEH04045) |
OKEH04045 |
Aviva Systems Biology |
96 Wells |
EUR 652.8 |
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
LIF, Mouse Recombinant , 10MIU/ml |
L4501-001 |
GenDepot |
1ml |
EUR 1744.8 |
Mouse LIF Recombinant Protein Lyophilized |
IMSLIFRLY5UG |
Innovative research |
each |
EUR 317 |
|
Description: Mouse LIF Recombinant Protein Lyophilized |
Human CellExp? LIF, mouse recombinant |
7268-10 |
Biovision |
each |
EUR 444 |
Mouse LIF protein, C-His tag |
PRP1126-100ug |
Abbkine |
100 μg |
EUR 379 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-1mg |
Abbkine |
1 mg |
EUR 2509 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-20ug |
Abbkine |
20 μg |
EUR 149 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-5ug |
Abbkine |
5 μg |
EUR 59 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102 |
Neuromics |
5 ug |
EUR 522 |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102-B |
Neuromics |
each |
EUR 436.5 |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1, (10ug) |
MC208887 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2, (10ug) |
MC208888 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Recombinant Mouse Lif Protein, No Tag |
E40MOP2217 |
EnoGene |
20ug |
EUR 495 |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 1, (10ug) |
MG223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 2, (10ug) |
MG223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1 |
MR223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2 |
MR223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif sgRNA CRISPR Lentivector set (Mouse) |
K3872501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse) |
4-PAA085Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF) |
LIF, Leukemia inhibitory factor, murine (mouse) |
RC234-18 |
Bio Basic |
5ug |
EUR 125.26 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
20-abx067761 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-1mg |
Abbexa |
1 mg |
EUR 3801.6 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x10g |
Abbexa |
3x10 µg |
EUR 393.6 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x2g |
Abbexa |
3x2 µg |
EUR 276 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx067761-10g |
Abbexa |
10 µg |
EUR 212.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx067761-50g |
Abbexa |
50 µg |
EUR 387.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx067761-100g |
Abbexa |
100 µg |
EUR 550 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-10mg |
Abbexa |
10 mg |
EUR 325 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-25mg |
Abbexa |
25 mg |
EUR 3287.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-5mg |
Abbexa |
5 mg |
EUR 225 |
Mouse LIF Protein, His Tag (MALS verified) |
LIF-M5227 |
ACROBIOSYSTEMS |
1mg |
EUR 321 |
|
Description: Mouse LIF, His Tag (LIF-M5227) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Phe 203 (Accession # P09056-1). |
Mouse LIF Protein, Tag Free (MALS verified) |
LIF-M5219 |
ACROBIOSYSTEMS |
20ug |
EUR 2856.9 |
|
Description: Mouse LIF Protein, Tag Free (LIF-M5219) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Phe 203 (Accession # P09056-1). |
LIF Antibody |
6245-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
LIF Antibody |
6245-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
LIF Antibody |
25283-100ul |
SAB |
100ul |
EUR 468 |
LIF Antibody |
36950 |
SAB |
100ul |
EUR 319 |
LIF Antibody |
36950-100ul |
SAB |
100ul |
EUR 302.4 |
LIF Antibody |
E036950 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
LIF Antibody |
E91288 |
EnoGene |
100μg |
EUR 255 |
Description: Available in various conjugation types. |
LIF Antibody |
E38PA4058 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
LIF Antibody |
E315544 |
EnoGene |
100ug/200ul |
EUR 295 |
Description: Available in various conjugation types. |
LIF antibody |
70R-12299 |
Fitzgerald |
100 ug |
EUR 343 |
|
Description: Rabbit polyclonal LIF antibody |
LIF antibody |
70R-14100 |
Fitzgerald |
100 ug |
EUR 519 |
|
Description: Affinity purified Rabbit polyclonal LIF antibody |
LIF Antibody |
5216-100 |
Biovision |
each |
EUR 379.2 |
LIF Antibody |
5216-30T |
Biovision |
each |
EUR 175.2 |
LIF antibody |
70R-6230 |
Fitzgerald |
50 ug |
EUR 467 |
|
Description: Rabbit polyclonal LIF antibody |
LIF antibody |
70R-51295 |
Fitzgerald |
100 ul |
EUR 242 |
|
Description: Purified Polyclonal LIF antibody |
LIF Antibody |
1-CSB-PA004761 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
LIF Antibody |
1-CSB-PA012928ESR2HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
LIF Antibody |
1-CSB-PA198481 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100 |
LIF Antibody |
F49998-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
LIF Antibody |
F49998-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
LIF Antibody |
R30639 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. It is produced in high amounts by the human endometrium and the trophoblast itself, and its receptors are present on cytotrophoblast cells. LIF could thus play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. |
LIF Antibody |
R31467 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. This gene is mapped to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF is produced in high amounts by the human endometrium and the trophoblast itself, and LIF receptors are present on cytotrophoblast cells. It could, thus, play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. |
LIF Antibody |
R36251-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: Leukemia inhibitory factor |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
AP75318 |
SAB |
1mg |
EUR 3209 |
|
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-10ug |
Novoprotein |
10ug |
EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-50ug |
Novoprotein |
50ug |
EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
LIF Protein Vector (Mouse) (pPM-C-HA) |
PV196580 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-HA) |
PV196584 |
ABM |
500 ng |
EUR 723.6 |
LIF |
cyt-644 |
ProSpec Tany |
5µg |
EUR 60 |
Description: Recombinant Human Leukemia Inhibitory Factor |
LIF |
E8ER1912-32 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
LIF Protein Vector (Mouse) (pPB-C-His) |
PV196578 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-N-His) |
PV196579 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-His) |
PV196581 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-C-His) |
PV196582 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-N-His) |
PV196583 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-His) |
PV196585 |
ABM |
500 ng |
EUR 723.6 |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-24Tests |
Elabscience Biotech |
24 Tests |
EUR 180 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-48Tests |
Elabscience Biotech |
48 Tests |
EUR 546 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-96Tests |
Elabscience Biotech |
96 Tests |
EUR 682 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-96Tests10 |
Elabscience Biotech |
96 Tests *10 |
EUR 6820 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-96Tests5 |
Elabscience Biotech |
96 Tests *5 |
EUR 3410 |
|
Description: Sandwich |
Anti-Human LIF R alpha Antibody |
101-M554 |
ReliaTech |
100 µg |
EUR 399 |
Description: The activities of the pleiotropic cytokine LIF are mediated through a high-affinity heterodimeric receptor complex consisting of two membrane glycoproteins: an alpha subunit (LIF R alpha, also known as LIF R beta and CD118) that binds LIF with low affinity and the 130 kDa (gp130) subunit that does not bind LIF by itself, but is required for high-affinity binding of LIF by the complex. |
Mouse Lif/ Leukemia inhibitory factor ELISA Kit |
E1656Mo |
Sunlong |
1 Kit |
EUR 543 |
|
Description: Differentiation-stimulating factor,D factor |
Mouse Lif(Leukemia inhibitory factor) ELISA Kit |
EM0237 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 46.9pg/ml |
Mouse Lif / Leukemia inhibitory factor ELISA Kit |
E0085m |
EIAab |
96T |
EUR 776 |
anti-LIF |
YF-PA12952 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to LIF |
Mouse LIF Protein (Ser 24-Phe 203) [His] |
VAng-1946Lsx-20g |
Creative Biolabs |
20 µg |
EUR 588 |
Description: Mouse LIF protein, His tag, expressed in human 293 cells. (Uniprot ID: P09056) |
Mouse LIF Protein (Ser 24-Phe 203) [His] |
VAng-1946Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1050 |
Description: Mouse LIF protein, His tag, expressed in human 293 cells. (Uniprot ID: P09056) |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), PE |
4-PAA085Mu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with PE. |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), APC |
4-PAA085Mu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with APC. |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), Cy3 |
4-PAA085Mu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with Cy3. |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), HRP |
4-PAA085Mu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with HRP. |
Recombinant Mouse LIF Protein, Untagged, E.coli-1mg |
QP4235-1mg |
EnQuireBio |
1mg |
EUR 3189.6 |
Recombinant Mouse LIF Protein, Untagged, E.coli-5ug |
QP4235-5ug |
EnQuireBio |
5ug |
EUR 163.2 |
Mouse LIF Recombinant Protein Tag Free Lyophilized |
IMSLIFRTFLY50UG |
Innovative research |
each |
EUR 681 |
|
Description: Mouse LIF Recombinant Protein Tag Free Lyophilized |
Recombinant Mouse LIF Protein, Untagged, E.coli-20ug |
QP4235-20ug |
EnQuireBio |
20ug |
EUR 284.4 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), FITC |
4-PAA085Mu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with FITC. |
Recombinant Mouse LIF Protein, Untagged, E.coli-100ug |
QP4235-100ug |
EnQuireBio |
100ug |
EUR 729.6 |
Recombinant Mouse LIF Protein, Untagged, E.coli-500ug |
QP4235-500ug |
EnQuireBio |
500ug |
EUR 1992 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3872502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3872503 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3872504 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Mouse Leukemia Inhibitory Factor (LIF) CLIA Kit |
abx195395-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Mouse LIF Recombinant Protein (Animal Free) Lyophilized |
IMSLIFRAFLY5UG |
Innovative research |
each |
EUR 333 |
|
Description: Mouse LIF Recombinant Protein (Animal Free) Lyophilized |
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
abx254611-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
abx574566-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Mu |
DL Develop |
96T |
EUR 432 |
|
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Mu-48T |
DL Develop |
48T |
EUR 586.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Mu-96T |
DL Develop |
96T |
EUR 762 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Leukemia inhibitory factor,LIF Elisa kit |
EK731218 |
AFG Bioscience LLC |
96 Wells |
EUR 0.76 |
Mouse Leukemia inhibitory factor,LIF ELISA kit |
EKC37279-5x96T |
Biomatik Corporation |
5x96T |
EUR 4283.55 |
However, the administration of urologic sufferers throughout the COVID-19 pandemic is carried out in Europa on a excessive commonplace. Therefor the danger of secondary hurt to our sufferers is anticipated to be reasonably minimal in the long term.